Home > News > featured news > Alight Announces Network Agreement With Children’s Hospital Colorado

FUTURE OF HEALTHCARE

Alight Announces Network Agreement With Children’s Hospital Colorado

Alight Solutions and Children’s Hospital Colorado | September 09, 2022 | Read time : 02:00 min

Alight, Inc. a leading cloud-based human capital technology and services provider announced an institutional agreement with Children’s Hospital Colorado one of the nation’s premier pediatric healthcare systems, to join Alight’s Expert Physician Network. This collaboration further expands Alight’s ability to provide employees and their loved ones guidance from the nation’s leading specialists when facing a new or complex diagnosis.

Through the agreement, families will now have access to the Children’s Colorado world-class network of physicians when seeking an expert opinion from Alight, providing the opportunity to drive more informed health decisions before, during and after treatment, as well as improved patient outcomes and lower costs for users.

“We are delighted to join forces with Children’s Colorado’s network of physicians, further demonstrating Alight’s leadership in healthcare navigation. Our expanding work among the nation’s preeminent hospitals accentuates our commitment to delivering the people we serve with the best guidance and technology possible, especially in this instance when children are directly impacted.”

Bipin Mistry, Chief Medical Officer at Alight

The Expert Physician Network is made up of over 2,000 of the nation’s top physicians. Using Alight’s award-winning platform for virtual expert opinions, these specialists collaborate with Alight’s team to respond to participant questions, provide guidance on diagnoses and treatment options they have received from their provider, and work together with other leading specialists to deliver multidisciplinary opinions when needed.

“By providing this service, we can provide more children the comprehensive, world-class expertise offered by Children’s Colorado, while keeping them close to home,” said Raphe Schwartz, Chief Strategy Officer at Children’s Hospital Colorado. “With this collaboration, we are thrilled to be able to support children and families nationwide by providing them with high-quality, family-centered guidance when they need an expert opinion.”

About Alight Solutions
Alight is a leading cloud-based human capital technology and services provider that powers confident health, wealth and wellbeing decisions for 36 million people and dependents. Our Alight Worklife® platform combines data and analytics with a simple, seamless user experience. Supported by our global delivery capabilities, Alight Worklife is transforming the employee experience for people around the world. With personalized, data-driven health, wealth, pay and wellbeing insights, Alight brings people the security of better outcomes and peace of mind throughout life’s big moments and most important decisions.

About Children’s Hospital Colorado
Children’s Hospital Colorado is one of the nation’s leading and most expansive nonprofit pediatric healthcare systems with a mission to improve the health of children through patient care, education, research and advocacy. Founded in 1908 and recognized as a top 10 children’s hospital by U.S. News & World Report, Children’s Colorado has established itself as a pioneer in the discovery of innovative and groundbreaking treatments that are shaping the future of pediatric healthcare worldwide. Children’s Colorado offers a full spectrum of family-centered care at its urgent, emergency and specialty care locations throughout Colorado, including an academic medical center on the Anschutz Medical Campus in Aurora, hospitals in Colorado Springs, Highlands Ranch and Broomfield, and outreach clinics across the region.

Spotlight

RAY in Healthcare

RAY in Healthcare - Transforming patient safety and quality of care with Smart, data-driven biosafety solutions

More featured news

Spotlight

RAY in Healthcare

RAY in Healthcare - Transforming patient safety and quality of care with Smart, data-driven biosafety solutions

Related News

HEALTH TECHNOLOGY, MEDICAL DEVICES

QooQoo Retained by Perimeter Medical Imaging AI to Drive Adoption of Innovative Tissue Margin Visualization Technology

Businesswire | April 11, 2023

QooQoo, a growing healthcare marketing agency in Southern California, announced that it has been retained by Perimeter Medical Imaging AI, a medical technology company with headquarters in Toronto, ON and Dallas, TX. Using their Business Before Brand methodology, QooQoo will create an omni-channel adoption and awareness campaign for Perimeter Medical’s innovative S-Series OCT device, a pioneering high-resolution intraoperative imaging technology. Clay Daniells, QooQoo founder and CEO, says partnering with Perimeter Medical is an exciting opportunity to impact clinicians across multiple specialties. “With real-time margin visualization inside the operating room, surgical oncologists can better evaluate whether or not they have excised all of the tissue associated with residual disease, in that moment. This technology is a game changer for surgeons concerned with taking excess tissue or the various risks surrounding re-excision.” “We are excited to partner with QooQoo as we articulate our unique value proposition and accelerate our commercial momentum, placing Perimeter’s S-Series OCT medical imaging system in hospitals across the U.S.,” says Linda Thomas, Marketing Director at Perimeter Medical. “We’re confident their unique strategic and creative capabilities, combined with their medical device knowledge, will serve us well.” About Perimeter Medical Imaging AI, Inc. Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., the FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level.

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

eVisit Announces the Acquisition of Bluestream Health

Prnewswire | April 28, 2023

eVisit, the leading virtual care operating platform for health systems and large, complex healthcare delivery organizations, announced it has acquired Bluestream Health, an innovative digital front door and virtual care workflow solution that manages patient and provider interactions throughout the care delivery process. Terms of the acquisition were not announced. With this acquisition, eVisit augments its highly innovative capabilities with complementary digital front doors and integrated language services for patients to seamlessly access care. eVisit's operating platform automates patient navigation and organizes patients and clinicians in one streamlined view, helping clinicians manage patient volumes more efficiently. The platform supports the distribution of digital care strategies that enable multiple clinicians to serve many patients simultaneously. This results in increased satisfaction for patients and clinicians, improved outcomes, and financial resiliency for healthcare delivery organizations. "We are honored to welcome Bluestream Health's customers and talented team to eVisit," said Sachin Agrawal, CEO of eVisit. "eVisit and Bluestream share a common ethos of empowering complex healthcare delivery organizations in their journey to transform care with a digital-first approach. We believe that such organizations require a dedicated operating platform to combine historically-disparate capabilities. Bluestream accelerates the execution of eVisit's strategic value to the organizations we serve." eVisit now empowers over 100 healthcare delivery organizations spanning 2,000 sites of care with a highly-configurable platform to deliver high-quality virtual care. Over 275,000 clinicians across all 50 states have access to eVisit to facilitate the delivery of millions of encounters annually. "eVisit is the right strategic partner to further Bluestream's mission of bringing virtual care to patients, developing innovative workflow tools, and driving better health outcomes," said Matthew Davidge, CEO of Bluestream Health. One of Bluestream's most successful client partnerships has served MedStar Health, the largest healthcare provider in Maryland and the Washington, D.C., region, in becoming nationally recognized for leveraging connected care models to strengthen patient access, clinical teams, and innovation outcomes. "eVisit takes its core strategy of creating the market-leading virtual care platform for health systems and other complex healthcare delivery organizations to the next level with their acquisition of Bluestream Health," said Bill Sheahan, Chief Innovation Officer, MedStar Health, and Executive Director, MedStar Institute for Innovation. "Our partnership with Bluestream has been essential in establishing and scaling telehealth throughout MedStar Health and it has enhanced visit quality, provider satisfaction, and business results in the process. With this news, MedStar Health welcomes advancing this successful partnership with eVisit to further accelerate the functionality, integration, and innovative possibilities of telehealth offerings within our care delivery model." About eVisit eVisit is the leading virtual care operating platform for innovative health systems and large, complex healthcare delivery organizations. Backed by Goldman Sachs Asset Management, the platform supports seamless integration of virtual care initiatives across service lines with configurable workflows to increase access, improve quality, and optimize clinical teams to utilize their full skills and experience while improving financial resilience for the health system. eVisit is trusted by leading health systems, and other large, complex healthcare delivery organizations.

HEALTHCARE ANALYTICS

Intelligent Medical Objects Announces the Acquisition of Melax Technologies Inc.

Businesswire | May 23, 2023

Intelligent Medical Objects (IMO), a leading provider of clinical terminology management and data quality solutions for healthcare, announced that it has acquired Melax Technologies, Inc. (Melax Tech). Melax Tech empowers the healthcare and life sciences industries through use of Artificial Intelligence (AI) and Natural Language Processing (NLP) technologies to extract information from biomedical textual data to solve real-world problems. The acquisition of Melax Tech will enhance IMO’s portfolio of healthcare data solutions and enable IMO to expand its offerings to various segments in the healthcare market to tackle diverse problems like improving clinical and administrative workflows, clinical research, and patient outcomes. “Today marks an exciting moment for IMO as we complete our first acquisition,” said Ann Barnes, Chief Executive Officer at IMO. “Combining Melax Tech’s analytics and NLP capabilities with IMO’s clinical terminology and data quality platform will enable healthcare organizations to have a more comprehensive solution for both clinical operation and research. The acquisition will also help extend our state-of-the-art capabilities to payer, pharmaceutical, and life science companies.” For nearly 30 years, IMO solutions have helped physicians document in their own words while capturing the right codes behind the scenes. IMO is the clinical terminology foundation in all major EHRs and 89% of US clinicians use IMO solutions. IMO is the catalyst that enables accurate documentation, precise population cohorting, optimized reimbursements, robust analytics, and better care decisions to optimize patient outcomes. Melax Tech is trusted by 650+ leading organizations for a variety of use cases, including advanced applications for cohort discovery, clinical trials optimization, and knowledge integration. “We are thrilled to join forces with IMO and combine our NLP expertise with their clinical terminology and knowledge management solutions,” said Andre Pontin, CEO of Melax Tech. “Together, we will be able to offer healthcare organizations a powerful suite of solutions that will enable them to improve patient outcomes and reduce costs.” About IMO Intelligent Medical Objects is a healthcare data enablement company that ensures clinical data integrity and quality — making patient information fit-for-purpose across the healthcare ecosystem, from hospitals to health information exchanges to payers, and beyond. IMO’s vast footprint in EHRs powers our ability to capture and preserve clinical intent at the highest level of specificity. Our secure technology platform and products then help our clients to transform and extract the greatest value from their data. In short, IMO is the catalyst that enables accurate documentation, precise population cohorting, optimized reimbursements, robust analytics, and better care decisions to optimize patient outcomes.